Skip to main content
. 2010 May;12(3):292–299. doi: 10.2353/jmoldx.2010.090139

Figure 2.

Figure 2

Morphological parameters that might interfere in the sensitivity of the KRAS mutational study. The samples were evaluated to establish the percentage of relevant lymphocytes (>10% in a ×20 field), (A) versus no lymphocytes (B); and relevant extracellular mucin (>50% of the tumor) (C) versus no mucin (D).